NSG 420 - ATI Pharm focused review Exam (elaborations)

NSG 420 - ATI Pharm focused review/NSG 420 - ATI Pharm focused review. 1. Substance Use and Other Disorders and Dependencies - (1) a. Substance Use Disorders: Expected Prescription for Smoking Cessation (Active Learning Template - Medication, RM Pharm RN 8.0 Chp 12) i. Bupropion should not be used with patients who have an increased risk of seizures. ii. Patients that use bupropion should avoid caffeine and other stimulants to avoid insomnia. iii. The intended effects of bupropion are to decrease cravings for nicotine and lessen the effects of withdrawal. 2. Adverse Effects/Contraindications/Side Effects/Interactions - (8) a. Airflow Disorders: Contraindications for a Client Who Is Taking Albuterol for Asthma (Active Learning Template - Basic Concept, RM Pharm RN 8.0 Chp 17) i. Albuterol is contraindicated with patients with tachydysrhythmia. ii. Beta blockers should not be used with tricyclic antidepressants because eit increases the risk tachycardia and angina. iii. Caution should be used with patients that have diabetes mellitus,